Case Report
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Mar 26, 2024; 12(9): 1634-1643
Published online Mar 26, 2024. doi: 10.12998/wjcc.v12.i9.1634
Low-molecular-weight heparin and preeclampsia — does the sword cut both ways? Three case reports and review of literature
Dan Shan, Tao Li, Xi Tan, Ya-Yi Hu
Dan Shan, Tao Li, Xi Tan, Ya-Yi Hu, Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu 610000, Sichuan Province, China
Dan Shan, Tao Li, Xi Tan, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu 610000, Sichuan, China
Author contributions: Shan D, Hu YY, and Li T made substantial contributions to conception and design; Shan D, Tan X and Li T helped in drafting the manuscript; Hu YY supervised of this study and gave final approval of the version to be published; all authors read and approved the final manuscript.
Supported by National Natural Science Foundation of China, No. 82301924.
Informed consent statement: Written informed consent was obtained from the three patients for publication of this case series report and any accompanying images.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ya-Yi Hu, MD, Chairman, Chief Doctor, Director, Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, No. 20 Renmin South Road, Section 3, Chengdu 610000, Sichuan Province, China. sometreasure@sina.cn
Received: October 20, 2023
Peer-review started: October 20, 2023
First decision: January 25, 2024
Revised: February 3, 2024
Accepted: March 1, 2024
Article in press: March 1, 2024
Published online: March 26, 2024
Processing time: 157 Days and 7.1 Hours
Core Tip

Core Tip: Benefits and risks of low molecular weight heparins in pregnant patients diagnosed with preeclampsia should be carefully assessed. Strict control of blood pressure is needed to prevent further bleeding events.